Endometrial Cancer Trial, Recruiting (NCT03366051)

Endometrial Cancer Trial, Recruiting NCT03366051 Sponsor: AC Camargo Cancer Center Condition: Endometrial Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT03366051 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Endometrial Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with a high-grade form of uterine cancer (specifically grade 3 endometrioid, serous, clear cell, or carcinosarcoma types)
You have a lower-grade endometrioid cancer (grade 1 or 2) that has spread more than halfway through the muscle wall of the uterus
You have a lower-grade endometrioid cancer (grade 1 or 2) that has spread into the cervix
Your doctors have assessed that you are healthy enough to safely undergo a surgical procedure to remove lymph nodes
You are willing and able to give your consent to take part in the trial

Who may not be able to join:

You have already had a hysterectomy (surgery to remove the uterus) performed at a different hospital or medical centre
Your cancer has already spread outside the uterus, for example to the lining of the abdomen, other organs, or nearby lymph nodes
You have previously had a surgical procedure to remove pelvic lymph nodes

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 5 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Glauco Baiocchi, MD, PhD, Department of Gynecologic Oncology - AC Camargo Cancer Center

Phone: 551121895110

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT03366051

Sponsor: AC Camargo Cancer Center

Phase: Not Applicable

Status: Recruiting

Condition: Endometrial Cancer

Trial contact: 551121895110

More information: https://clinicaltrials.gov/study/NCT03366051

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with a high-grade form of uterine cancer (specifically grade 3 endometrioid, serous, clear cell, or carcinosarcoma types)
You have a lower-grade endometrioid cancer (grade 1 or 2) that has spread more than halfway through the muscle wall of the uterus
You have a lower-grade endometrioid cancer (grade 1 or 2) that has spread into the cervix
Your doctors have assessed that you are healthy enough to safely undergo a surgical procedure to remove lymph nodes
You are willing and able to give your consent to take part in the trial

Who may not be able to join:

You have already had a hysterectomy (surgery to remove the uterus) performed at a different hospital or medical centre
Your cancer has already spread outside the uterus, for example to the lining of the abdomen, other organs, or nearby lymph nodes
You have previously had a surgical procedure to remove pelvic lymph nodes

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 5 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

AC Camargo Cancer Center

Registry

ClinicalTrials.gov

Start date

22 December 2017

Est. completion

20 December 2024

Where this trial is recruiting

🇧🇷 Brazil

Primary endpoints

Recurrence

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov